Calmus, Yvon

Publishing since 1997 (Senior)

Has published 37 publications in 13 years

Number of publications published per year by Calmus, Yvon. (Source : PubMed)

Distribution of publications types for Calmus, Yvon. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Calmus Y, Dharancy S. [Indications of mTOR inhibitors in liver transplantation]  Gastroenterol. Clin. Biol.  2009;33 Suppl 4  
•  Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, Lorho R, Deray G, Launay-Vacher V, Pageaux GP. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.  Liver Transpl.  2009;15;9  
•  Wyplosz B, Van der Vliet D, Consigny PH, Calmus Y, Mamzer-Bruneel MF, Guillemain R, Malvy D, Samuel D, Vittecoq D, Launay O. [Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)]  Med Mal Infect  2009;39;4  
•  Boleslawski E, BenOthman S, Grabar S, Correia L, Podevin P, Chouzenoux S, Soubrane O, Calmus Y, Conti F. CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation.  Clin Transplant  2008;22;4  
•  Dharancy S, Podevin P, Aoudjehane L, Batteux F, Rosenberg AR, Soubrane O, Calmus Y, Conti F. Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation.  Transplantation  2007;83;7  
•  Carrière M, Pène V, Breiman A, Conti F, Chouzenoux S, Meurs E, Andrieu M, Jaffray P, Grira L, Soubrane O, Sogni P, Calmus Y, Chaussade S, Rosenberg AR, Podevin P. A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication.  J. Med. Virol.  2007;79;2  
•  Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, Dumortier J, Salamé E, Calmus Y, Maugendre D. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.  Liver Transpl.  2007;13;1  
•  Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Compagnon P, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouillères O, Cherqui D, Duvoux C. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients.  World J. Gastroenterol.  2006;12;45  
•  Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.  Liver Transpl.  2006;12;12  
•  Pageaux GP, Rostaing L, Calmus Y, Duvoux C, Vanlemmens C, Hardgwissen J, Bernard PH, Barbotte E, Vercambre L, Bismuth M, Puche P, Navarro F, Larrey D. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.  Liver Transpl.  2006;12;12  

[ See timeline ] [ See all publications ]